Testing effectiveness (Phase 2)Study completedNCT00003850
What this trial is testing
Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 47